These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12118474)

  • 1. Regulation of dietary supplements: FDA's strategic plan.
    Levitt JA
    Food Drug Law J; 2002; 57(1):1-13. PubMed ID: 12118474
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA has substantial and sufficient authority to regulate dietary supplements.
    McNamara SH; Siegner AW
    Food Drug Law J; 2002; 57(1):15-24. PubMed ID: 12118477
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DSHEA provisions confine FDA's authority to issue regulations that concern allegedly adulterated dietary supplements.
    McNamara SH; Siegner AW; Phelps EP
    Food Drug Law J; 1999; 54(4):595-8. PubMed ID: 11824456
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of dietary supplements: five years of DSHEA.
    Khatcheressian LA
    Food Drug Law J; 1999; 54(4):623-44. PubMed ID: 11824458
    [No Abstract]   [Full Text] [Related]  

  • 8. Dietary supplements: background for dialogue between the industry and the medical profession.
    Friede AI
    Food Drug Law J; 1998; 53(3):413-20. PubMed ID: 10346719
    [No Abstract]   [Full Text] [Related]  

  • 9. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
    Pinco RG; Rubin PD
    Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
    [No Abstract]   [Full Text] [Related]  

  • 10. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE; Taylor DA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA's response to food, dietary supplement, and cosmetic adverse events.
    Bren L
    FDA Consum; 2003; 37(4):12-3. PubMed ID: 12971342
    [No Abstract]   [Full Text] [Related]  

  • 12. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
    Soller RW; Rice LG; Ambrose PJ
    Food Drug Law J; 2007; 62(2):375-86. PubMed ID: 17632967
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 14. Food industry initiatives to improve the FDA's food ingredient review processes.
    Pape SM
    Food Drug Law J; 1996; 51(3):413-21. PubMed ID: 11797718
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicine. Ephedra--scientific evidence versus money/politics.
    Wolfe SM
    Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of GRAS to the functional food and nutraceutical industries.
    Burdock GA; Carabin IG; Griffiths JC
    Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
    Dodge T; Kaufman A
    Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary supplements and lessons to be learned from GRAS.
    Burdock GA
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary supplements: what is in the public's best interest?
    Talbott SM
    Science; 1999 Dec; 286(5448):2269-70; author reply 2270-1. PubMed ID: 10636786
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
    McNamara SH
    Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.